QUADSMaster December 27, 2022 Nanoparticles to treat aging and age-related diseases – interview with Louis Hawthornes
QUADSMaster December 17, 2022 Targeting the immune system to extend healthspan – interview with Dr. Hans Keirstead
October 25, 2023 Turn Bio receives positive feedback following an FDA INTERACT meeting to advance epigenetic reprogramming for skin rejuvenation into clinical trials
October 25, 2023 Turn Bio receives positive feedback following an FDA INTERACT meeting to advance epigenetic reprogramming for skin rejuvenation into clinical trials